Posted on 6月 16, 20236/16/23
Digital Guide to Commercializing Complex Therapeutics
Posted on 5月 31, 20235/31/23
Patient-centric Approach to Clinical Trial Support Leveraging Medical Information Services
Posted on 5月 15, 20235/15/23
Role of Decentralized Trials for Newer Drug Approvals
Posted on 4月 17, 20234/17/23
What EVERSANA’s Growing Abstract Count at ISPOR U.S. Means to the HEOR Industry
Posted on 11月 13, 202211/13/22
Establishing the Patient Access Mission During Clinical Development
Posted on 7月 27, 20227/27/22
EVERSANA’s Continued Commitment to Rare Disease
Posted on 7月 14, 20217/14/21
Navigating the Transition to Post-Approval Pharmacovigilance With EVERSANA and ArisGlobal
Posted on 1月 19, 20211/19/21
The 10-Year Test: Is It Possible to Plan Launch During Clinical Development?
Posted on 12月 16, 202012/16/20